Market Research Hub

Brain Tumor Diagnosis and Treatments Market Anticipated to Grow at 8.5% CAGR Through 2025, Driven by Growth in Technological Advances

The demand in the global market for brain tumor diagnosis and treatments is anticipated to increase at a potent CAGR of 8.5% during the forecast period of 2017 to 2025.


Albany, NY -- (SBWIRE) -- 09/19/2017 -- Since the past few years, doctors and researchers are collaborating on the development of new advances in brain tumor therapies. According to a latest study, several advanced medications are available to treat the brain tumors. Due to this, an estimated 22,850 cases diagnosed with primary cancerous tumors of the brain in the U.S. Market Research Hub (MRH) has freshly announced the addition of a new report, in which detailed market outlook of brain tumor diagnosis and treatments have been discussed. The study is titled as "Brain Tumor Diagnosis and Treatments Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025" which offers precise forecast analysis at the global scale and further studies the changing trends in the market. As per the report, increasing pharmaceutical R&D spending is expected to provide the lucrative growth for the global brain tumor treatment market over the forecasted period.

Request Free Sample Report :

Geographically, the research majorly focuses on regions such as North America, Europe, Asia, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025. In the first part, the report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data and verifiable projections about market size. According to the study key highlights, the demand in the global brain tumor diagnosis projected to increment at a healthy CAGR of 8.5% during the forecast period of 2017 to 2025, estimating it to be worth US$840.7 mn by 2025, mounting noticeably from its valuation of US$406.0 mn in 2016. Increasing consumer awareness regarding the latest technological advancements in therapies and medications are responsible for the growth of global brain tumor treatment market.

Brain tumor is the abnormal growth of cells in the tissue of the brain. There are many different types of brain tumors. Some are benign, or non-cancerous, while others are classified as malignant, or cancerous. Brain cancer tumor treatment depends on the type of cancer, the diagnosis and the stage of advancement. At present, surgery remains a mainstay treatment for brain tumors, but advances in technology and new clinical trials mean patients have more treatment options which lead to quicker recoveries. Moreover, the market has been segmented by product type, diagnosis type, treatment type and geography. Based on the product type, it includes primary brain tumors (meningioma, gliomas, astrocytomas, pituitary tumors and others) and secondary brain tumors.

Browse Full Report with TOC -

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the brain tumor diagnosis and treatments market and could influence the market in the near future. Increasing prevalence of brain cancer, innovations in drug delivery to brain cancer cells, and expanding market for the treatment of brain cancer associated symptoms are some of the key factors boosting the demand in the global brain tumor diagnosis & treatments market. Rising aging population is also a vital factor for the market, as this population subset is more prone to neurological conditions.

The report also profiles key players operating in the brain tumor diagnosis and treatments market which are GE Healthcare, AstraZeneca, Merck & Co., Inc., Hitachi Medical Corporation, Shimadzu Corporation, Carestream Health, Philips Healthcare, Pfizer, Inc., Siemens Healthineers, Toshiba Medical Systems Corporation and other prominent players.

Enquire about this Report -

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -